Flindokalner (BMS-204352, MaxiPost) is a drug which acts as an opener of BKCa large-conductance, calcium-activated potassium channels. It was unsuccessful in clinical trials as a potential treatment for stroke, but continues to be researched for other applications such as Fragile X syndrome.
See also Chlorzoxazone
References